Skip to main content

Find Clinical Trials

Home
Conditions
Leishmaniasis

Clinical trial condition

Leishmaniasis

Explore clinical trials studying Leishmaniasis. Study availability and eligibility vary by location and protocol.

97 public trials 8 recruiting studies

Refine in advanced search Browse all conditions

Leishmaniasis trial results

Completed

Safety and Efficacy of Low-Dose Pentavalent Antimony for Treatment of Cutaneous Leishmaniasis

NCT00317980

Conditions: Cutaneous Leishmaniasis, Euglenozoa Infections, Infections, +9 more
Locations: Núcleo de Medicina Tropical, University of Brasilia Brasília, Federal District, Brazil

View Trial Details

Completed

A Phase II Study To Assess Safety and Efficacy Of Short-Course Regimens Of Amphotericin B Emulsion In Kala-Azar

NCT00497601

Conditions: Euglenozoa Infections, Infections, Leishmaniasis, +5 more
Locations: Kala-azar Medical Research Center Muzaffarpur, Bihar, India

View Trial Details

Completed

An Open Lable Randomised Study to Assess the Safety and Efficacy of Short Course Paromomycin in Visceral Leishmaniasis

NCT00629031

Conditions: Euglenozoa Infections, Infections, Leishmaniasis, +5 more
Locations: Kala-azar Medical Research Center, Rambag Road Varanasi, India

View Trial Details

Completed

Combination Chemotherapy for the Treatment of Indian Kala-Azar

NCT00370825

Conditions: Euglenozoa Infections, Infections, Leishmaniasis, +5 more
Locations: Kala-azar Medical Research Center Muzaffarpur, Bihar, India

View Trial Details

Completed

Amphotericin B Treatment in Visceral Leishmaniasis

NCT00310505

Conditions: Euglenozoa Infections, Infections, Leishmaniasis, +5 more
Locations: Kala-azar Medical Research Center Muzaffarpur, Bihar, India

View Trial Details

Completed

Imiquimod Plus Antimony Immunochemotherapy for Cutaneous Leishmaniasis

NCT00257530

Conditions: Cutaneous Leishmaniasis, Euglenozoa Infections, Infections, +9 more
Locations: UPCH Cusco, Peru

IMT Alexander Von Humboldt Lima, Peru

View Trial Details

Completed

Safety and Immunogenicity of a Vaccine for Cutaneous Leishmaniasis Using Recombinant Human Interleukin-12 and Aluminum Hydroxide Gel as Adjuvants

NCT00001906

Conditions: Cutaneous Leishmaniasis, Euglenozoa Infections, Infections, +9 more
Locations: National Institute of Allergy and Infectious Diseases (NIAID) Bethesda, Maryland, United States

View Trial Details